School of Medicine will welcome Class of 2022 with White Coat Ceremony

Translate to Spanish or other 102 languages!

- Advertisement -

Mega Doctor News

RIO GRANDE VALLEY, TEXAS – The University of Texas Rio Grande Valley School of Medicine will welcome its third class of students into the medical profession with a White Coat Ceremony, 10 a.m. Saturday, July 28, at the Performing Arts Center at Harlingen Consolidated Independent School District (CISD), 3217 West Wilson Road in Harlingen.

This year’s keynote speaker is Dr. John E. Prescott, M.D., chief academic officer for the Association of American Medical Colleges. Students from Harlingen CISD will participate in the ceremony, further strengthening ties between the School of Medicine and the communities it serves.

- Advertisement -

The Arnold P. Gold Foundation started the White Coat Ceremony in 1993 to welcome new medical students to the healthcare profession. Almost all medical schools in the United States today, as well as schools for other healthcare professions, perform such ceremonies, which serve as a rite of passage for medical students.

Each student, carrying a white coat, walks across the stage and the school leadership helps them don the white coat for the first time.

In addition to the robing ceremony, students also will take the Hippocratic Oath, which acknowledges their primary role as caregivers.

The ceremony will be available via live stream at http://www.utrgv.edu/live

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS McAllen Launches Naming Contest for Advanced Surgical Robot

Using advanced robotic technology to assist surgeons in performing complex procedures with enhanced precision, dexterity and control, robotic surgery represents one of the most significant advancements in modern medicine.

DHR Health Raises Over $520K at 20th “Fishing for Hope” Event

DHR Health made a big splash at the 20th Annual “Fishing for Hope” Tournament, held on August 22 at Jim’s Pier in South Padre Island, raising an impressive grand total of $524,130.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral Marks Suicide Prevention Month with Community Chalk Event

Every 11 minutes, someone in the United States dies by suicide, according to the Centers for Disease Control and Prevention (CDC), making it one of the nation's leading causes of death.
- Advertisement -